APA

Sabat M., Vanrens J. C., Brugel T. A., Maier J., Laufersweiler M. J., Golebiowski A., De B., Easwaran V., Hsieh L. C., Rosegen J., Berberich S., Suchanek E. & Janusz M. J. (20061006). The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck). : Bioorganic & medicinal chemistry letters.

Chicago

Sabat Mark, Vanrens John C, Brugel Todd A, Maier Jennifer, Laufersweiler Matthew J, Golebiowski Adam, De Biswanath, Easwaran Vijayasurian, Hsieh Lily C, Rosegen Jeff, Berberich Steve, Suchanek Eric and Janusz Michael J. 20061006. The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck). : Bioorganic & medicinal chemistry letters.

Harvard

Sabat M., Vanrens J. C., Brugel T. A., Maier J., Laufersweiler M. J., Golebiowski A., De B., Easwaran V., Hsieh L. C., Rosegen J., Berberich S., Suchanek E. and Janusz M. J. (20061006). The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck). : Bioorganic & medicinal chemistry letters.

MLA

Sabat Mark, Vanrens John C, Brugel Todd A, Maier Jennifer, Laufersweiler Matthew J, Golebiowski Adam, De Biswanath, Easwaran Vijayasurian, Hsieh Lily C, Rosegen Jeff, Berberich Steve, Suchanek Eric and Janusz Michael J. The development of novel 1,2-dihydro-pyrimido[4,5-c]pyridazine based inhibitors of lymphocyte specific kinase (Lck). : Bioorganic & medicinal chemistry letters. 20061006.